Experimental models
Pediatric Oncology, ISSN: 2191-0812, Page: 129-147
2021
- 17Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures17
- Readers17
- 17
Book Chapter Description
To understand the pathophysiologic mechanisms of human bone and soft tissue sarcomas, and develop interventions to treat them, it became necessary to study sarcomas outside of the human body and deconstruct the events leading to full tumor formation. This has taken the form of human tumor-derived cell lines grown in culture, human tumor-derived cell lines and primary human tumors grown as xenografts in immunocompromised laboratory mice, genetically defined sarcoma cell lines, genetically engineered mouse models, and novel models of sarcoma arising spontaneously in domesticated animals or developed in lower organisms including zebrafish and fruit flies. This chapter reviews the uses of these approaches in understanding bone and soft tissue sarcomas and complements other recent sarcoma model reviews (O’Brien et al. 2012; Kashi et al. 2015).
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85092064954&origin=inward; http://dx.doi.org/10.1007/978-3-030-51160-9_10; http://link.springer.com/10.1007/978-3-030-51160-9_10; https://dx.doi.org/10.1007/978-3-030-51160-9_10; https://link.springer.com/chapter/10.1007/978-3-030-51160-9_10
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know